Innovation Pharmaceuticals Stock Price Prediction

IPIX Stock  USD 0  0.0002  13.33%   
At this time, the relative strength index (RSI) of Innovation Pharmaceuticals' share price is approaching 38. This usually indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Innovation Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

38

 
Oversold
 
Overbought
The successful prediction of Innovation Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Innovation Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Innovation Pharmaceuticals hype-based prediction, you can estimate the value of Innovation Pharmaceuticals from the perspective of Innovation Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Innovation Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Innovation because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Innovation Pharmaceuticals after-hype prediction price

    
  USD 0.001378  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Innovation Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innovation Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.00030.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Innovation Pharmaceuticals. Your research has to be compared to or analyzed against Innovation Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Innovation Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Innovation Pharmaceuticals.

Innovation Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Innovation Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Innovation Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Innovation Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Innovation Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Innovation Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Innovation Pharmaceuticals' historical news coverage. Innovation Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 30.29, respectively. We have considered Innovation Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0
0
After-hype Price
30.29
Upside
Innovation Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Innovation Pharmaceuticals is based on 3 months time horizon.

Innovation Pharmaceuticals Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Innovation Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Innovation Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Innovation Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.03 
30.29
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0
0
5.97 
0.00  
Notes

Innovation Pharmaceuticals Hype Timeline

Innovation Pharmaceuticals is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Innovation is forecasted to increase in value after the next headline, with the price projected to jump to 0.001378 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is estimated to be 5.97%, whereas the daily expected return is currently at 1.03%. The volatility of related hype on Innovation Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. Innovation Pharmaceuticals currently holds about 2.97 M in cash with (6.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next forecasted press release will be uncertain.
Check out Innovation Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Innovation Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Innovation Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Innovation Pharmaceuticals' future price movements. Getting to know how Innovation Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Innovation Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
QEBRVirtual Medical International 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
HYEXGrey Cloak Tech 0.00 0 per month 0.00  0.08  1.36  0.00  64.50 
CSTFCuraScientific Corp 0.00 0 per month 19.87  0.17  100.00 (50.00) 150.00 
WRHLFLove Hemp Group 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
TMSHTransGlobal Assets 0.00 0 per month 13.06  0.13  75.00 (33.33) 142.86 
GCANGreater Cannabis 0.00 0 per month 12.09  0.11  25.00 (28.57) 70.00 
GXXYGalexxy Holdings 0.00 0 per month 6.30  0.03  18.30 (13.08) 49.75 
GSACGelStat Corp 0.00 0 per month 8.58  0.06  33.33 (25.00) 86.67 
DVLPGolden Developing Solutions 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NUNZNunzia Pharmaceutical 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Innovation Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Innovation price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Innovation using various technical indicators. When you analyze Innovation charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Innovation Pharmaceuticals Predictive Indicators

The successful prediction of Innovation Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Innovation Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Innovation Pharmaceuticals based on analysis of Innovation Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Innovation Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Innovation Pharmaceuticals's related companies.

Story Coverage note for Innovation Pharmaceuticals

The number of cover stories for Innovation Pharmaceuticals depends on current market conditions and Innovation Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Innovation Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Innovation Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Innovation Pharmaceuticals Short Properties

Innovation Pharmaceuticals' future price predictability will typically decrease when Innovation Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Innovation Pharmaceuticals often depends not only on the future outlook of the potential Innovation Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Innovation Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding472.2 M
Short Long Term Debt250 K
Shares Float439.3 M

Additional Tools for Innovation Pink Sheet Analysis

When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.